Telomere repeat amplification protocol (TRAP) in situ reveals telomerase activity in three cell types in effusions: Malignant cells, proliferative mesothelial cells, and lymphocytes

Modern Pathology

Volumn 18, Issue 2, 2005, Pages 189-196

  Zendehrokh, Nooreldin ^a   Dejmek, Annika ^b,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Malmo University Hospital   (Sweden)

Author keywords

Cancer; Cytology; Effusion; Lymphocytes; Mesothelial cells; Telomerase; TRAP in situ

Indexed keywords

TELOMERASE;

ANALYTIC METHOD; ARTICLE; ASCITES FLUID; CANCER CELL; CELL PROLIFERATION; CELL TYPE; CYTOLOGY; DIAGNOSTIC PROCEDURE; EFFUSION; ENZYME ACTIVITY; FLUORESCENCE; HUMAN; HUMAN CELL; LYMPHOCYTE; MESOTHELIUM CELL; PERICARDIAL EFFUSION; PLEURA CAVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

EID: 13244281603     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3800278     Document Type: Article

References (34)

1. Rhyu MS. Telomeres, telomerase and immortality. J Natl Cancer Inst 1995;87:884-894.
2. Blackburn EH. Structure and function of telomeres. Nature 1991;350:569-573.
3. Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention; fundamental differences in human and mouse telomerase biology. Nat Med 2000;6:847-851.
4. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-791.
5. Shay JW, Wright WE. Telomerase activity in human cancer. Curr Opin Oncol 1996;8:66-71.
6. Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev 2002;66:407-425.
7. Granger MP, Wright WE, Shay JW. Telomerase in cancer and aging. Crit Rev Oncol Hematol 2002;41:29-40.
8. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994;266:2011-2015.
9. Piatyszek MA, Kim NW, Weinrich SL, et al. Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 1995;17:1-15.
10. Mu XC, Brien TP, Ross JS, et al. Telomerase activity in benign and malignant cytologic fluids. Cancer (Cancer Cytopathol) 1999;87:93-99,
11. Hess JL, Highsmith WE, Telomerase detection in body fluids. Clin Chem 2002;48:18-24.
12. Cunningham V, Markham N, Shroyer AL, et al. Detection of telomerase expression in fine-needle aspirations and fluids. Diagn Cytopathol 1998;18:431-436.
13. Toshima S, Arai T, Yasuda Y, et al. Cytological diagnosis and telomerase activity of cells in effusions of body cavities. Oncol Rep 1999;6:199-203.
14. Yang CT, Lee MH, Lan RS, et al. Telomerase activity in pleural effusions: diagnostic significance. J Clin Oncol 1998;16:567-573.
15. Tangkijvanich P, Tresukosol D, Sampatanukul P, et al. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites. Clin Cancer Res 1999;5:2470-2475.
16. Murakami J, Nagai N, Ohama K, Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer. J Int Med Res 1998;26:129-139.
17. Braunschweig R, Yan P, Guilleret I, et al. Detection of malignant effusions: comparison of telomerase assay and cytological examination. Diagn Cytopathol 2001;24:174-180.
18. Ohyashiki K, Ohyashiki JH, Nishimaki J, et al. Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay. Cancer Res 1997;57:2100-2103.
19. Dejmek A, Yahata N, Ohyashiki K, et al. Correlation between morphology and telomerase activity in cells from exfoliative lung cytologic specimens. Cancer (Cancer Cytopathol) 2000;90:117-125.
20. Ohyashiki K, Yahata N, Ohyashiki JH, et al. A combination of semi-quantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia. Cancer 1998;83:2554-2560.
21. Yahata N, Ohyashiki K, Ohyashiki JH, et al. Telomerase activity in lung cancer cells obtained from bronchial washings. J Natl Cancer Inst 1998;90:684-690.
22. Dejmek A, Yahata N, Ohyashiki K, Ebihara Y, et al. In situ telomerase activity in pleural effusions: a promising marker for malignancy. Diagn Cytopathol 2000;24:11-15.
23. Dejmek A, Hjerpe A. Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma, and mesotheliosis: stepwise logistic regression analysis. Cytopathology 2000;11:8-17.
24. Brockstedt U, Gulyas M, Dobra K, et al. An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma. Am J Clin Pathol 2000;114:203-209.
25. Nurminen M, Dejmek A, Martensson G, et al. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin Chem. 1994;40:777-780.
26. Counter CM, Gupta J, Harley CB, et al. Telomerase activity in normal leukocytes and in hematologic malignancies. Blood 1995;85:2315-2320.
27. Norrback KF, Dahlenborg K, Carlsson R, et al. Telomerase activation in normal B lymphocytes and non-Hodgkin's lymphomas. Blood 1996;88:222-229.
28. Saldanha SN, Andrews LG, Tollefsbol TO. Analysis of telomerase activity and detection of its catalytic subunit, hTERT. Anal Biochem 2003;315:1-21.
29. Braunschweig R, Guilleret I, Delacretaz F, et al. Pitfalls in TRAP assay in routine detection of malignancy in effusions. Diagn Cytopathol 2001;25:225-230.
30. Gollahon LS, Holt SE. Alternative methods of extracting telomerase activity from human tumor samples. Cancer Lett 2000;159:141-149.
31. Nagel H, Schlott T, Schulz GM, et al. Gene expression analysis of the catalytic subunit of human telomerase (hEST2) in the differential diagnosis of serous effusions. Diagn Mol Pathol 2001;10:60-65.
32. Dhaene K, Hubner R, Kumar-Singh S, et al. Telomerase activity in human pleural mesothelioma. Thorax 1998;53:915-918.
33. Kumaki F, Kawai T, Churg A, et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol 2002;26:365-370.
34. Foddis R, De Rienzo A, Broccoli D, et al. SV40 infection induces telomerase activity in human mesothelial cells. Oncogene 2002;21:1434-1442.